Department of Defense Chemical Biological and Medical Systems Continues Funding Under Development Contract With Cleveland BioLabs for Entolimod(TM) (CBLB502)

[at noodls] – Download PDF BUFFALO, N.Y., Oct. 25, 2012 (GLOBE NEWSWIRE) — Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced that the U.S. Department of Defense (DoD) Chemical Biological and Medical Systems (CBMS) … more

View todays social media effects on CBLI

View the latest stocks trending across Twitter. Click to view dashboard